# Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

> **NCT03541694** · — · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 622 (actual)

## Conditions studied

- Yellow Fever

## Interventions

- **BIOLOGICAL:** Stamaril®

## Key facts

- **NCT ID:** NCT03541694
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-11
- **Primary completion:** 2018-05-30
- **Final completion:** 2018-05-30
- **Target enrollment:** 622 (ACTUAL)
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03541694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03541694, "Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03541694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*